ESSA Pharma Inc
NASDAQ:EPIX

Watchlist Manager
ESSA Pharma Inc Logo
ESSA Pharma Inc
NASDAQ:EPIX
Watchlist
Price: 1.61 USD -4.73% Market Closed
Market Cap: 71.5m USD

Relative Value

There is not enough data to reliably calculate the relative value of EPIX.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EPIX Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
6.9
vs History
vs Industry
Median 3Y
-4.6
Median 5Y
-6.8
Industry
22.9
Forward
-2.2
vs History
vs Industry
Median 3Y
-5.5
Median 5Y
-8.9
Industry
19.7
vs History
vs Industry
Median 3Y
-5.5
Median 5Y
-8.9
Industry
23.5
vs History
87
vs Industry
68
Median 3Y
0.9
Median 5Y
1.9
Industry
2.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.4
vs History
28
vs Industry
3
Median 3Y
281.3
Median 5Y
-1 197.6
Industry
9.1
vs History
15
vs Industry
17
Median 3Y
0.7
Median 5Y
-2.9
Industry
3.8
vs History
17
vs Industry
15
Median 3Y
0.7
Median 5Y
-2.9
Industry
3.8
Forward
1.3
vs History
15
vs Industry
17
Median 3Y
0.9
Median 5Y
-4.1
Industry
4.9
vs History
15
vs Industry
13
Median 3Y
0.9
Median 5Y
-4.1
Industry
3.5
vs History
vs Industry
18
Median 3Y
-72.5
Median 5Y
23.4
Industry
4.6

Multiples Across Competitors

EPIX Competitors Multiples
ESSA Pharma Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
ESSA Pharma Inc
NASDAQ:EPIX
71.5m USD 0 -2.5 1.3 1.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 980 418.7 -166 256.7 -201 888.7 -199 584.9
US
Abbvie Inc
NYSE:ABBV
328B USD 5.7 78.9 15.1 22.3
US
Amgen Inc
NASDAQ:AMGN
150.3B USD 4.4 25.3 13.8 22.7
US
Gilead Sciences Inc
NASDAQ:GILD
136.2B USD 4.7 22.8 9.9 13.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.4B USD 10.3 -115.6 24.5 25.7
US
Epizyme Inc
F:EPE
94.1B EUR 2 014 -513.9 -559.6 -544.7
AU
CSL Ltd
ASX:CSL
120.6B AUD 5.1 28.3 17.4 21.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
65.3B USD 4.6 14.5 13.1 14.7
US
Seagen Inc
F:SGT
39.3B EUR 19.4 -59.5 -64.1 -57.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
38.1B USD 16.2 -141.3 -631.4 -316.4
P/S Multiple
Revenue Growth P/S to Growth
CA
ESSA Pharma Inc
NASDAQ:EPIX
Average P/S: 3 498 250.3
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
34 980 418.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.7
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.4
4%
1.1
US
Gilead Sciences Inc
NASDAQ:GILD
4.7
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.3
10%
1
US
E
Epizyme Inc
F:EPE
2 014
N/A N/A
AU
CSL Ltd
ASX:CSL
5.1
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.6
5%
0.9
US
S
Seagen Inc
F:SGT
19.4
30%
0.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
16.2
29%
0.6
P/E Multiple
Earnings Growth PEG
CA
ESSA Pharma Inc
NASDAQ:EPIX
Average P/E: 34
Negative Multiple: -2.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -166 256.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
78.9
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
25.3
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.8
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -115.6 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -513.9 N/A N/A
AU
CSL Ltd
ASX:CSL
28.3
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.5
7%
2.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -141.3 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
ESSA Pharma Inc
NASDAQ:EPIX
Average EV/EBITDA: 13.6
1.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -201 888.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.1
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
13.8
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.5
17%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -559.6 N/A N/A
AU
CSL Ltd
ASX:CSL
17.4
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.1
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -64.1 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -631.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
ESSA Pharma Inc
NASDAQ:EPIX
Average EV/EBIT: 17.5
1.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -199 584.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.3
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
22.7
31%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.7
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.7
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -544.7 N/A N/A
AU
CSL Ltd
ASX:CSL
21.8
14%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.7
13%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.8 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -316.4 N/A N/A